WestEnd Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
WestEnd Advisors's MRK Position: Q2 2026 in Review
WestEnd Advisors increased its Merck (MRK) stake by 9% in Q2 2026, buying an estimated $702 and bringing the position to 73 shares worth $9.38K. The position accounts for ﹤0.01% of the portfolio, ranked #97.
WestEnd Advisors first reported a position in MRK in Q3 2019 and has held it in 18 quarters since. The position peaked at $42.6M in Q1 2024. 3,832 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- WestEnd Advisors held 73 shares of Merck worth $9.38K as of Q2 2026.
- WestEnd Advisors bought 6 Merck shares in Q2 2026, an estimated $702.
- Merck made up ﹤0.01% of WestEnd Advisors's portfolio in Q2 2026, its #97 holding.
- WestEnd Advisors first reported a position in Merck in Q3 2019 and has held it in 18 quarters since.
- WestEnd Advisors's Merck position peaked at $42.6M in Q1 2024.
- 3,832 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on WestEnd Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.